Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,474 | 70 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $337.33 | 15 | $0 (2024) |
| Nevro Corp. | $321.01 | 7 | $0 (2024) |
| ABBVIE INC. | $188.10 | 12 | $0 (2024) |
| Medtronic, Inc. | $178.26 | 9 | $0 (2023) |
| Amgen Inc. | $135.09 | 6 | $0 (2022) |
| SCILEX PHARMACEUTICALS INC. | $85.05 | 5 | $0 (2024) |
| Saluda Medical Americas, Inc. | $49.83 | 6 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $43.77 | 2 | $0 (2021) |
| Biohaven Pharmaceutical Holding Company Ltd. | $37.31 | 2 | $0 (2022) |
| PFIZER INC. | $23.63 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $374.78 | 13 | Nevro Corp. ($214.59) |
| 2023 | $278.40 | 13 | Abbott Laboratories ($158.15) |
| 2022 | $489.15 | 26 | ABBVIE INC. ($130.12) |
| 2021 | $331.80 | 18 | Medtronic, Inc. ($68.33) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $3.41 | General |
| Category: Spinal Cord Stimulator | ||||||
| 12/10/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $8.29 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/31/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $9.68 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/03/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: Spinal Cord Stimulator | ||||||
| 06/18/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $27.93 | General |
| Category: Neuromodulation | ||||||
| 05/29/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $6.03 | General |
| Category: Spinal Cord Stimulator | ||||||
| 05/23/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $75.96 | General |
| Category: Spinal Cord Stimulator | ||||||
| 05/02/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Analgesic | ||||||
| 04/03/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $27.63 | General |
| Category: Neuromodulation | ||||||
| 02/29/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Analgesic | ||||||
| 02/27/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $10.95 | General |
| Category: Spinal Cord Stimulator | ||||||
| 01/09/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $138.63 | General |
| Category: Spinal Cord Stimulator | ||||||
| 12/18/2023 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Neuromodulation | ||||||
| 12/06/2023 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: Neuromodulation | ||||||
| 12/06/2023 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: Neuromodulation | ||||||
| 12/04/2023 | Scilex Pharmaceuticals Inc. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Analgesic | ||||||
| 11/20/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Neuromodulation | ||||||
| 09/25/2023 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Neuromodulation | ||||||
| 09/21/2023 | Scilex Pharmaceuticals Inc. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Analgesic | ||||||
| 08/16/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $29.05 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 08/16/2023 | Scilex Pharmaceuticals Inc. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Analgesic | ||||||
| 05/25/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: PAIN MANAGEMENT | ||||||
| 05/17/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/25/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Neuromodulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 1,328 | 2,928 | $2.0M | $267,980 |
| 2022 | 10 | 1,761 | 3,519 | $2.3M | $311,764 |
| 2021 | 7 | 1,148 | 1,886 | $1.1M | $184,485 |
| 2020 | 7 | 1,150 | 1,841 | $915,513 | $164,368 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 308 | 523 | $657,170 | $123,429 | 18.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 344 | 1,312 | $732,096 | $94,525 | 12.9% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 315 | 542 | $474,792 | $32,619 | 6.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 128 | 204 | $53,856 | $10,696 | 19.9% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 31 | 31 | $30,783 | $5,878 | 19.1% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 187 | 188 | $5,076 | $724.63 | 14.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 15 | 128 | $1,280 | $108.36 | 8.5% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 332 | 545 | $718,070 | $132,015 | 18.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 389 | 1,339 | $747,804 | $105,033 | 14.0% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 343 | 617 | $540,492 | $37,527 | 6.9% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 66 | 67 | $44,406 | $12,686 | 28.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 141 | 184 | $48,576 | $10,219 | 21.0% |
| 96130 | Evaluation of psychological test, first hour | Office | 2022 | 78 | 82 | $73,100 | $6,060 | 8.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 30 | 30 | $20,130 | $2,492 | 12.4% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2022 | 343 | 616 | $16,632 | $2,415 | 14.5% |
| 72148 | Mri scan of lower spinal canal without contrast | Office | 2022 | 16 | 16 | $42,000 | $1,901 | 4.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 23 | 23 | $10,350 | $1,417 | 13.7% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 255 | 350 | $465,500 | $85,939 | 18.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 358 | 861 | $262,605 | $66,979 | 25.5% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 271 | 387 | $339,012 | $23,934 | 7.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 71 | 86 | $18,576 | $4,437 | 23.9% |
| 96130 | Psychological testing evaluation by qualified health care professional, first 60 minutes | Office | 2021 | 38 | 39 | $23,400 | $2,317 | 9.9% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2021 | 49 | 57 | $2,850 | $456.84 | 16.0% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2021 | 106 | 106 | $2,862 | $422.34 | 14.8% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2020 | 247 | 320 | $331,740 | $77,801 | 23.5% |
About Shelby Real, PAC
Shelby Real, PAC is a Physician Assistant healthcare provider based in Carson City, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/13/2018. The National Provider Identifier (NPI) number assigned to this provider is 1720557374.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Shelby Real, PAC has received a total of $1,474 in payments from pharmaceutical and medical device companies, with $374.78 received in 2024. These payments were reported across 70 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,474).
As a Medicare-enrolled provider, Real has provided services to 5,387 Medicare beneficiaries, totaling 10,174 services with total Medicare billing of $928,597. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Carson City, NV
- Active Since 11/13/2018
- Last Updated 07/21/2021
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1720557374
Products in Payments
- Senza (Device) $214.59
- ETERNA (Device) $147.23
- Aimovig (Biological) $135.09
- PROCLAIM (Device) $127.94
- INTELLIS ADAPTIVESTIM (Device) $109.93
- Omnia (Device) $106.42
- ZTLido (Drug) $85.05
- NURTEC ODT (Drug) $81.08
- QULIPTA (Drug) $77.67
- Proclaim IPG (Device) $62.16
- BOTOX (Biological) $56.62
- UBRELVY (Drug) $53.81
- Evoke (Device) $49.83
- INTELLIS (Device) $38.18
- RESTORE (Device) $30.15
- Olinvyk (Drug) $20.65
- Dayvigo (Drug) $20.11
- PENNSAID (Drug) $17.95
- SEGLENTIS (Drug) $16.04
- COLOGUARD DNA CAPTURE REAGENTS (Device) $11.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Carson City
John Larsen, Pa-C, PA-C
Physician Assistant — Payments: $11,700
Olivia Franke, Pa-C, PA-C
Physician Assistant — Payments: $6,380
Ashley Allen, Pa-C, PA-C
Physician Assistant — Payments: $4,338
Ryan Tognotti, Pac, PAC
Physician Assistant — Payments: $4,212
Ana Turner, Pa-C, PA-C
Physician Assistant — Payments: $3,968
Sydnee Eck, Pa-C, PA-C
Physician Assistant — Payments: $3,106